Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase-Reference-Cited by-同舟云学术

Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase

Published:2018-06 Issue: Volume:9 Page:347-357
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Paul Biswajit,Ibarra Guillermo S. Romano,Hubbard Nicholas,Einhaus Teresa,Astrakhan Alexander,Rawlings David J.,Kiem Hans-Peter,Peterson Christopher W.

Funder

Core Center of Excellence in Hematology

Fred Hutchinson Cancer Research Center

Hutch United

NIH

National Heart, Lung, and Blood Institute

José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research

Fred Hutch Endowed Chair for Cell and Gene Therapy

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases;Perez;Nat. Biotechnol.,2008

2. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo;Holt;Nat. Biotechnol.,2010

3. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV;Tebas;N. Engl. J. Med.,2014

4. Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates;Peterson;Blood,2016

5. Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy;Peterson;PLoS Pathog.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultra-high efficiency T cell reprogramming at multiple loci with SEED-Selection;2024-02-07

2. MTORas a selectable genomic harbor for CRISPR-engineered CAR-T cell therapy;2023-09-16

3. Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing;Molecular Cancer;2023-06-26

4. Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates;Frontiers in Immunology;2023-05-03

5. Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication;Frontiers in Immunology;2022-03-21